Broad Institute’s CRISPR/Cas9 Patent EP2771468 Revoked

Broad Institute’s CRISPR/Cas9 Patent EP2771468 Revoked

Schlich represented Opponent 1 and is pleased to report as follows. The proceedings focused on the issue of priority right under the Paris Convention, a treaty providing a harmonized system for international patent priority rights. After nearly two days of...
More Guidance on Claiming Priority

More Guidance on Claiming Priority

EPO Decision T1201/14 of 9 February 2017 was published on 5 September 2017 and provides further guidance on the issue of priority. The case is an appeal against an opposition which revoked the patent on grounds of lack of novelty. In the Opposition, the OD found no...